Bitcoin

The event highlights growing concerns about reproducibility in life sciences, which could undermine investor confidence in biotech and AI-driven drug discovery. For crypto, it reinforces the value of immutable, verifiable data—blockchain's core promise—but this is a long-term narrative shift, not a near-term price driver.

More than 18,000 questionable images were found in antibody catalogues of 15 companies, according to a science sleuth's findings published in Nature.

Antibody Image Scandal Revives Crypto's Data-Provenance Pitch

As science's image-integrity crisis deepens, crypto's immutable provenance rails become the unsexy 'verification layer' that could rescue reproducibility — and smart money is quietly rotating into that narrative.